{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:01:26Z","timestamp":1784566886598,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Singhealth Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"DOI":"10.1007\/s00417-026-07405-y","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T03:58:01Z","timestamp":1784519881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between pupil size and response to atropine therapy in the Atropine Treatment of Myopia study (ATOM2)"],"prefix":"10.1007","author":[{"given":"Daniel","family":"Peh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hla Myint","family":"Htoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"Suppl 1","key":"7405_CR1","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1016\/S0039-6257(99)00094-6","volume":"44","author":"H Matsumura","year":"1999","unstructured":"Matsumura H, Hirai H (1999) Prevalence of myopia and refractive changes in students from 3 to 17 years of age. Surv Ophthalmol 44(Suppl 1):S109\u2013115","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"7405_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.47102\/annals-acadmedsg.V33N1p27","volume":"33","author":"LL Lin","year":"2004","unstructured":"Lin LL, Shih YF, Hsiao CK, Chen CJ (2004) Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000. Ann Acad Med Singap 33(1):27\u201333","journal-title":"Ann Acad Med Singap"},{"issue":"1","key":"7405_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1167\/iovs.04-0565","volume":"46","author":"SM Saw","year":"2005","unstructured":"Saw SM, Tong L, Chua WH, Chia KS, Koh D, Tan DT et al (2005) Incidence and progression of myopia in Singaporean school children. Invest Ophthalmol Vis Sci 46(1):51\u201357","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"7405_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/iovs.62.5.2","volume":"62","author":"P Sankaridurg","year":"2021","unstructured":"Sankaridurg P, Tahhan N, Kandel H, Naduvilath T, Zou H, Frick KD, Marmamula S, Friedman DS, Lamoureux E, Keeffe J, Walline JJ, Fricke TR, Kovai V, Resnikoff S (2021) IMI Impact of Myopia. Invest Ophthalmol Vis Sci 62(5):2","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"7405_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1089\/jop.1999.15.85","volume":"15","author":"YF Shih","year":"1999","unstructured":"Shih YF, Chen CH, Chou AC, Ho TC, Lin LL, Hung PT (1999) Effects of different concentrations of atropine on controlling myopia in myopic children. J Ocul Pharmacol Ther 15(1):85\u201390","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"7405_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","volume":"119","author":"A Chia","year":"2012","unstructured":"Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, Tan D (2012) Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology 119(2):347\u2013354","journal-title":"Ophthalmology"},{"issue":"1","key":"7405_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","volume":"126","author":"JC Yam","year":"2019","unstructured":"Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E, Ko ST, Young AL, Tham CC, Chen LJ, Pang CP (2019) Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology 126(1):113\u2013124","journal-title":"Ophthalmology"},{"issue":"12","key":"7405_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1167\/iovs.66.12.39","volume":"66","author":"MA Bullimore","year":"2025","unstructured":"Bullimore MA, Saunders KJ, Baraas RC, Berntsen DA, Chen Z, Chia AWL, Goto S, Jiang J, Lan W, Logan NS, Najjar RP, Polling JR, Read SA, Woodman-Pieterse EC, Sz\u00e9ll N, Verkicharla PK, Wu PC, Zhu X, Loughman J, Nagra M, Phillips JR, Tran HDM, Vera-Diaz FA, Yam J, Liu YM, Singh SE, Wildsoet CF (2025) IMI-Interventions for Controlling Myopia Onset and Progression 2025. Invest Ophthalmol Vis Sci 66(12):39","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"7405_CR9","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.ajo.2015.01.029","volume":"159","author":"KL Loh","year":"2015","unstructured":"Loh KL, Lu Q, Tan D, Chia A (2015) Risk factors for progressive myopia in the atropine therapy for myopia study. Am J Ophthalmol 159(5):945\u2013949","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"7405_CR10","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.ophtha.2020.12.036","volume":"128","author":"FF Li","year":"2021","unstructured":"Li FF, Zhang Y, Zhang X, Yip BHK, Tang SM, Kam KW, Young AL, Chen LJ, Tham CC, Pang CP, Yam JC (2021) Age Effect on Treatment Responses to 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study. Ophthalmology 128(8):1180\u20131187","journal-title":"Ophthalmology"},{"issue":"5","key":"7405_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/iovs.62.5.3","volume":"62","author":"IG Morgan","year":"2021","unstructured":"Morgan IG, Wu PC, Ostrin LA, Tideman JWL, Yam JC, Lan W, Baraas RC, He X, Sankaridurg P, Saw SM, French AN, Rose KA, Guggenheim JA (2021) IMI Risk Factors for Myopia. Invest Ophthalmol Vis Sci 62(5):3","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"7405_CR12","doi-asserted-by":"publisher","first-page":"11729","DOI":"10.1038\/s41598-021-88719-1","volume":"11","author":"A Fu","year":"2021","unstructured":"Fu A, Stapleton F, Wei L, Wang W, Zhao B, Watt K, Yu S, Cui C, Lyu Y (2021) Risk factors for rapid axial length elongation with low concentration atropine for myopia control. Sci Rep 11(1):11729","journal-title":"Sci Rep"},{"issue":"4","key":"7405_CR13","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00417-022-05863-8","volume":"261","author":"WL Bai","year":"2023","unstructured":"Bai WL, Gan JH, Wei S, Li SM, An WZ, Liang XT, Tian JX, Yin L, Wang N (2023) Effect of low-dose atropine eyedrops on pupil metrics: results after half a year of treatment and cessation. Graefes Arch Clin Exp Ophthalmol 261(4):1177\u20131186","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"7405_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10384-021-00822-y","volume":"65","author":"O Hieda","year":"2021","unstructured":"Hieda O, Hiraoka T, Fujikado T, Ishiko S, Hasebe S, Torii H, Takahashi H, Nakamura Y, Sotozono C, Oshika T, Morimoto T, Nishida K, Nishikawa N, Song YS, Tokutake T, Nishi Y, Shigeno Y, Kurihara T, Negishi K, Tsubota K, Ono M, Nakai T, Tan D, Tanaka S, Kinoshita S (2021) ATOM-J. Study Group. Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study. Jpn J Ophthalmol 65(3):315\u2013325","journal-title":"Jpn J Ophthalmol"},{"issue":"6","key":"7405_CR15","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00431-023-04921-5","volume":"182","author":"W Wang","year":"2023","unstructured":"Wang W, Zhang F, Yu S, Ma N, Huang C, Wang M, Wei L, Zhang J, Fu A (2023) Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children - a prospective, randomized, double-masked, and crossover trial. Eur J Pediatr 182(6):2597\u20132606","journal-title":"Eur J Pediatr"},{"issue":"4","key":"7405_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1080\/02713683.2022.2162925","volume":"48","author":"I Sharma","year":"2023","unstructured":"Sharma I, Das GK, Rohatgi J, Sahu PK, Chhabra P, Bhatia R (2023) Low Dose Atropine in Preventing the Progression of Childhood Myopia: A Randomised Controlled Trial. Curr Eye Res 48(4):402\u2013407","journal-title":"Curr Eye Res"},{"issue":"1","key":"7405_CR17","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12886-023-03177-9","volume":"23","author":"NC Hansen","year":"2023","unstructured":"Hansen NC, Hvid-Hansen A, M\u00f8ller F, Bek T, Larsen DA, Jacobsen N, Kessel L (2023) Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety. BMC Ophthalmol 23(1):438","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"7405_CR18","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1111\/aos.15761","volume":"102","author":"J Loughman","year":"2024","unstructured":"Loughman J, Kobia-Acquah E, Lingham G, Butler J, Loskutova E, Mackey DA, Lee SSY, Flitcroft DI (2024) Myopia outcome study of atropine in children: Two-year result of daily 0.01% atropine in a European population. Acta Ophthalmol 102(3):e245\u2013e256","journal-title":"Acta Ophthalmol"},{"issue":"6 Suppl","key":"7405_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3171\/ped.2005.103.6.0496","volume":"103","author":"AN Boev","year":"2005","unstructured":"Boev AN, Fountas KN, Karampelas I, Boev C, Machinis TG, Feltes C, Okosun I, Dimopoulos V, Troup C (2005) Quantitative pupillometry: normative data in healthy pediatric volunteers. J Neurosurg 103(6 Suppl):496\u2013500","journal-title":"J Neurosurg"},{"issue":"1","key":"7405_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12886-020-01625-4","volume":"20","author":"DP Pi\u00f1ero","year":"2020","unstructured":"Pi\u00f1ero DP, de Fez D, Cabezos I, L\u00f3pez-Navarro A, Caballero MT, Camps VJ (2020) Intrasession repeatability of pupil size measurements under different light levels provided by a multidiagnostic device in healthy eyes. BMC Ophthalmol 20(1):354","journal-title":"BMC Ophthalmol"},{"issue":"10","key":"7405_CR21","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1136\/bjo.84.10.1173","volume":"84","author":"CJ Hammond","year":"2000","unstructured":"Hammond CJ, Snieder H, Spector TD, Gilbert CE (2000) Factors affecting pupil size after dilatation: the Twin Eye Study. Br J Ophthalmol 84(10):1173\u20131176","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"7405_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00417-003-0735-4","volume":"242","author":"EM Kohnen","year":"2004","unstructured":"Kohnen EM, Zubcov AA, Kohnen T (2004) Scotopic pupil size in a normal pediatric population using infrared pupillometry. Graefes Arch Clin Exp Ophthalmol 242(1):18\u201323","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"7405_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3928\/01913913-20150317-11","volume":"52","author":"JT Brown","year":"2015","unstructured":"Brown JT, Connelly M, Nickols C, Neville KA (2015) Developmental Changes of Normal Pupil Size and Reactivity in Children. J Pediatr Ophthalmol Strabismus 52(3):147\u2013151","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"9","key":"7405_CR24","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1097\/OPX.0000000000000893","volume":"93","author":"M Guillon","year":"2016","unstructured":"Guillon M, Dumbleton K, Theodoratos P, Gobbe M, Wooley CB, Moody K (2016) The Effects of Age, Refractive Status, and Luminance on Pupil Size. Optom Vis Sci 93(9):1093\u20131100","journal-title":"Optom Vis Sci"},{"issue":"1","key":"7405_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10286-019-00639-3","volume":"30","author":"M Winston","year":"2020","unstructured":"Winston M, Zhou A, Rand CM, Dunne EC, Warner JJ, Volpe LJ, Pigneri BA, Simon D, Bielawiec T, Gordon SC, Vitez SF, Charnay A, Joza S, Kelly K, Panicker C, Rizvydeen S, Niewijk G, Coleman C, Scher BJ, Reed DW, Hockney SM, Buniao G, Stewart T, Trojanowski L, Brogadir C, Price M, Kenny AS, Bradley A, Volpe NJ, Weese-Mayer DE (2020) Pupillometry measures of autonomic nervous system regulation with advancing age in a healthy pediatric cohort. Clin Auton Res 30(1):43","journal-title":"Clin Auton Res"},{"key":"7405_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cogpsych.2016.10.001","volume":"91","author":"JS Tsukahara","year":"2016","unstructured":"Tsukahara JS, Harrison TL, Engle RW (2016) The relationship between baseline pupil size and intelligence. Cogn Psychol 91:109\u2013123","journal-title":"Cogn Psychol"},{"issue":"1","key":"7405_CR27","doi-asserted-by":"publisher","first-page":"8228","DOI":"10.1038\/s41598-017-08246-w","volume":"7","author":"G Wainstein","year":"2017","unstructured":"Wainstein G, Rojas-L\u00edbano D, Crossley NA, Carrasco X, Aboitiz F, Ossand\u00f3n T (2017) Pupil Size Tracks Attentional Performance In Attention-Deficit\/Hyperactivity Disorder. Sci Rep 7(1):8228","journal-title":"Sci Rep"},{"issue":"2","key":"7405_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/dev.20352","volume":"51","author":"CJ Anderson","year":"2009","unstructured":"Anderson CJ, Colombo J (2009) Larger tonic pupil size in young children with autism spectrum disorder. Dev Psychobiol 51(2):207\u2013211","journal-title":"Dev Psychobiol"},{"issue":"11","key":"7405_CR29","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1007\/s00417-018-4112-8","volume":"256","author":"H Kaymak","year":"2018","unstructured":"Kaymak H, Fricke A, Mauritz Y, Lowinger A, Klabe K, Breyer D et al (2018) Short-term effects of low-concentration atropine eye drops on pupil size and accommodation in young adult subjects. Graefes Arch Clin Exp Ophthalmol 256(11):2211\u20132217","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"7405_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1167\/iovs.66.6.34","volume":"66","author":"B Lal","year":"2025","unstructured":"Lal B, Queener HM, Ostrin LA (2025) Dose Dependent Effects of Atropine on Static and Dynamic Pupil and Accommodation Metrics in Young Adults. Invest Ophthalmol Vis Sci 66(6):34","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"7405_CR31","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1111\/opo.13195","volume":"43","author":"FS Yii","year":"2023","unstructured":"Yii FS (2023) Emmetropic eye growth in East Asians and non-East Asians. Ophthalmic Physiol Opt 43(6):1412\u20131418","journal-title":"Ophthalmic Physiol Opt"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07405-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07405-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07405-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:01:36Z","timestamp":1784563296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07405-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":31,"alternative-id":["7405"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07405-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AC has received industry support for conferences and royalties. All other authors report no financial interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}